Duration of post-vaccination humoral immunity against yellow fever in children.
CONCLUSIONS: Analogous to previous findings in adults, these data support the need for revaccination of children living in areas with yellow fever virus circulation in humans or in other primates. The data also supported the change of a booster dose to 4 years of age for those primarily vaccinated for yellow fever in the first two years of life.
PMID: 31590934 [PubMed - as supplied by publisher]
Source: Vaccine - Category: Allergy & Immunology Authors: de Noronha TG, de Lourdes de Sousa Maia M, Geraldo Leite Ribeiro J, Campos Lemos JA, Maria Barbosa de Lima S, Martins-Filho OA, Campi-Azevedo AC, da Silva Freire M, de Menezes Martins R, Bastos Camacho LA, Collaborative Group for Studies of Yellow Fever V Tags: Vaccine Source Type: research
More News: Allergy & Immunology | Brazil Health | Children | Endemics | International Medicine & Public Health | Men | Primary Care | Study | Vaccines | WHO | Yellow Fever | Yellow Fever Vaccination